XML 55 R39.htm IDEA: XBRL DOCUMENT v3.5.0.2
Stockholders' Equity and Stock Compensation Plans (Tables)
12 Months Ended
Oct. 02, 2016
Stockholders' Equity and Stock Compensation Plans  
Schedule of the stock-based compensation and related income tax benefits

                                                                                                                                                                                          

 

 

Fiscal Year Ended

 

 

 

October 2,
2016

 

September 27,
2015

 

September 28,
2014

 

 

 

(in thousands)

 

Total stock-based compensation

 

$

12,964

 

$

10,926

 

$

10,374

 

Income tax benefit related to stock-based compensation

 

 

(4,656

)

 

(3,811

)

 

(3,696

)

​  

​  

​  

​  

​  

​  

Stock-based compensation, net of tax benefit

 

$

8,308

 

$

7,115

 

$

6,678

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

 

Schedule of stock option activity

                                                                                                                                                                                       

 

 

Number of
Options
(in thousands)

 

Weighted-
Average
Exercise Price
per Share

 

Weighted-
Average
Remaining
Contractual
Term
(in years)

 

Aggregate
Intrinsic Value
(in thousands)

 

 

 

    

 

 

 

Outstanding on September 27, 2015

 

 

2,985

 

$

23.71

 

 

 

 

 

 

 

Granted

 

 

242

 

 

27.16

 

 

 

 

 

 

 

Exercised

 

 

(839

)

 

30.04

 

 

 

 

 

 

 

Forfeited

 

 

(21

)

 

23.59

 

 

 

 

 

 

 

​  

​  

Outstanding at October 2, 2016

 

 

2,367

 

$

24.88

 

 

4.04

 

$

25,068

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

Vested or expected to vest at October 2, 2016

 

 

2,320

 

$

24.88

 

 

3.99

 

$

24,579

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

Exercisable on October 2, 2016

 

 

1,776

 

$

24.10

 

 

3.04

 

$

20,197

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

      

Schedule of assumptions used in the calculation of the fair value of stock options using the Black-Scholes option pricing model

                                                                                                                                                                                            

 

 

Fiscal Year Ended

 

 

October 2,
2016

 

September 27,
2015

 

September 28,
2014

Dividend yield

 

1.2%

 

1.0%

 

Expected stock price volatility

 

36.1% – 38.8%

 

36.2% – 38.8%

 

36.1% – 38.8%

Risk-free rate of return, annual

 

1.6% – 1.8%

 

1.5% – 1.7%

 

1.3% – 1.5%

 

Schedule of restricted stock activity

                                                                                                                                                                                                  

 

 

Number of
Shares
(in thousands)

 

Weighted-
Average Grant
Date Fair
Value

 

 

 

    

 

Nonvested balance at September 27, 2015

 

 

104

 

$

27.15

 

Granted

 

 

14

 

 

28.58

 

Vested

 

 

(49

)

 

28.58

 

Forfeited

 

 

(34

)

 

24.26

 

​  

​  

​  

​  


Nonvested balance at October 2, 2016


 


 

35


 


$

28.58


 

​  

​  

​  

​  

​  

​  

​  

​  


Vested or expected to vest at October 2, 2016


 


 

35


 


$

28.58


 

​  

​  

​  

​  

​  

​  

​  

​  

     

Schedule of performance-based awards

                                                                                                                                                                                           

 

 

Number of
Shares
(in thousands)

 

Weighted-
Average Grant
Date Fair
Value

 

 

 

    

 

Nonvested balance at September 27, 2015

 

 

139 

 

$

31.66 

 

Granted

 

 

138 

 

 

31.63 

 

​  

​  

​  

​  


Nonvested balance at October 2, 2016


 


 

277 


 


$

31.65 


 

​  

​  

​  

​  

​  

​  

​  

​  

       

Schedule of RSU activity

                                                                                                                                                                                        

 

 

Number of
Shares
(in thousands)

 

Weighted-
Average Grant
Date Fair
Value

 

 

 

    

 

Nonvested balance at September 27, 2015

 

 

483

 

$

26.75

 

Granted

 

 

217

 

 

27.14

 

Vested

 

 

(180

)

 

26.03

 

Forfeited

 

 

(21

)

 

27.11

 

​  

​  

​  

​  


Nonvested balance at October 2, 2016


 


 

499


 


$

27.16


 

​  

​  

​  

​  

​  

​  

​  

​  

         

Summary of shares purchased, weighted-average purchase price, cash received, and the aggregate intrinsic value for shares purchased under the ESPP

                                                                                                                                                                                           

 

 

Fiscal Year Ended

 

 

 

October 2,
2016

 

September 27,
2015

 

September 28,
2014

 

 

 

(in thousands, except for purchase price)

 

Shares purchased

 

 

209 

 

 

243 

 

 

245 

 

Weighted-average purchase price

 

$

22.54 

 

$

21.44 

 

$

22.99 

 

Cash received from exercise of purchase rights

 

$

4,707 

 

$

5,204 

 

$

5,604 

 

Aggregate intrinsic value

 

$

710 

 

$

1,277 

 

$

1,221 

 

 

Schedule of the assumptions used in the Black-Scholes option pricing model in estimating the grant date fair value of each award granted under the ESPP

                                                                                                                                                                                          

 

 

Fiscal Year Ended

 

 

 

October 2,
2016

 

September 27,
2015

 

September 28,
2014

 

Dividend yield

 

 

1.3 

%

 

1.1 

%

 

 

Expected stock price volatility

 

 

23.7 

%

 

23.7 

%

 

29.2 

%

Risk-free rate of return, annual

 

 

0.2 

%

 

0.2 

%

 

0.1 

%

Expected life (in years)